Peripartum kardiomyopati

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Peripartum kardiomyopati. / Bretler, Ditte-Marie; Jørgensen, Casper Haslund; Olesen, Jonas Bjerring; Gislason, Gunnar Hilmar; Hansen, Peter Riis; Bretler, Ditte-Marie; Jørgensen, Casper Haslund; Olesen, Jonas Bjerring; Gislason, Gunnar Hilmar; Hansen, Peter Riis.

I: Ugeskrift for læger, Bind 171, Nr. 1-2, 05.01.2009, s. 53-5.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bretler, D-M, Jørgensen, CH, Olesen, JB, Gislason, GH, Hansen, PR, Bretler, D-M, Jørgensen, CH, Olesen, JB, Gislason, GH & Hansen, PR 2009, 'Peripartum kardiomyopati', Ugeskrift for læger, bind 171, nr. 1-2, s. 53-5.

APA

Bretler, D-M., Jørgensen, C. H., Olesen, J. B., Gislason, G. H., Hansen, P. R., Bretler, D-M., Jørgensen, C. H., Olesen, J. B., Gislason, G. H., & Hansen, P. R. (2009). Peripartum kardiomyopati. Ugeskrift for læger, 171(1-2), 53-5.

Vancouver

Bretler D-M, Jørgensen CH, Olesen JB, Gislason GH, Hansen PR, Bretler D-M o.a. Peripartum kardiomyopati. Ugeskrift for læger. 2009 jan. 5;171(1-2):53-5.

Author

Bretler, Ditte-Marie ; Jørgensen, Casper Haslund ; Olesen, Jonas Bjerring ; Gislason, Gunnar Hilmar ; Hansen, Peter Riis ; Bretler, Ditte-Marie ; Jørgensen, Casper Haslund ; Olesen, Jonas Bjerring ; Gislason, Gunnar Hilmar ; Hansen, Peter Riis. / Peripartum kardiomyopati. I: Ugeskrift for læger. 2009 ; Bind 171, Nr. 1-2. s. 53-5.

Bibtex

@article{cbdceb5064b711df928f000ea68e967b,
title = "Peripartum kardiomyopati",
abstract = "Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition. Udgivelsesdato: 2009-Jan-5",
author = "Ditte-Marie Bretler and J{\o}rgensen, {Casper Haslund} and Olesen, {Jonas Bjerring} and Gislason, {Gunnar Hilmar} and Hansen, {Peter Riis} and Ditte-Marie Bretler and J{\o}rgensen, {Casper Haslund} and Olesen, {Jonas Bjerring} and Gislason, {Gunnar Hilmar} and Hansen, {Peter Riis}",
note = "Keywords: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors",
year = "2009",
month = jan,
day = "5",
language = "Dansk",
volume = "171",
pages = "53--5",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "1-2",

}

RIS

TY - JOUR

T1 - Peripartum kardiomyopati

AU - Bretler, Ditte-Marie

AU - Jørgensen, Casper Haslund

AU - Olesen, Jonas Bjerring

AU - Gislason, Gunnar Hilmar

AU - Hansen, Peter Riis

AU - Bretler, Ditte-Marie

AU - Jørgensen, Casper Haslund

AU - Olesen, Jonas Bjerring

AU - Gislason, Gunnar Hilmar

AU - Hansen, Peter Riis

N1 - Keywords: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors

PY - 2009/1/5

Y1 - 2009/1/5

N2 - Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition. Udgivelsesdato: 2009-Jan-5

AB - Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition. Udgivelsesdato: 2009-Jan-5

M3 - Tidsskriftartikel

VL - 171

SP - 53

EP - 55

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 1-2

ER -

ID: 19867482